WFH NETWORK

2019 WFH Humanitarian Aid Program Impact Report released

The lack of access to care, clotting factor concentrates and treatment for people affected by a bleeding disorder in developing countries is an urgent and important public health challenge. The WFH Humanitarian Aid Program was developed to address this issue by working with World Federation of Hemophilia (WFH) national member organizations (NMOs) to provide continued access to treatment for emergency situations, acute bleeds, corrective surgeries, and prophylaxis for young children.

The WFH Humanitarian Aid Program aims to have an impact on the global bleeding disorders community by:

Facilitating sustainable care

Supporting outreach and identification

Improving quality of life

Involving governments

Ensuring the viability of corrective surgeries

The WFH Humanitarian Aid Program: Impact Report 2019—released today—shows the impact that the WFH Humanitarian Aid Program has had on the global bleeding disorders community. Now, more people than ever have hope that they can have a better quality of life. This success is a direct result of a collective effort between the WFH, pharmaceutical partners, governments, and the global bleeding disorders community.

241M+ IUs of factor distributed

65,000+ bleeding episodes managed

19,800+ hemophilia A and B patients treated

None of this would be possible without the generous support of our corporate partners. Their multi-year commitments to supply predictable donated treatment products, and their generous financial support ensure that the WFH is able to reach its goal of bringing sustainable change to those living with little or no access to treatment.

Mafaal Saidy, father of Mutala Saidy, The Gambia

“I feel really thankful [for WFH Humanitarian Aid Program] help and support… without it, my son’s life would be at risk and he might even have lost his life.”

In 2020, despite the COVID-19 pandemic, the WFH Humanitarian Aid Program continues to diligently work to find ways to ship treatment product, and is replacing in-person education programs with virtual education programs.

To read the full report, WFH Humanitarian Aid Program: Impact Report 2019, please click here.

About the WFH Humanitarian Aid Program

The expanded WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi Genzyme and Sobi, our Visionary Contributors; Grifols, CSL Behring, GC Pharma, our Corporate partners; and Roche and Bayer, our newest donors. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.